{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:49:10Z","timestamp":1791478150663,"version":"4.3.4"},"reference-count":126,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NS9984"],"award-info":[{"award-number":["NS9984"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.urolonc.2012.01.013","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T04:19:09Z","timestamp":1332908349000},"page":"951-965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Thirty years of research on infection and prostate cancer: No conclusive evidence for a link. A systematic review"],"prefix":"10.1016","volume":"31","author":[{"given":"Jan","family":"Hrbacek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hamsikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Tachezy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Heracek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2012.01.013_bib1","first-page":"212","article-title":"Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2012.01.013_bib2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","article-title":"Estimates of cancer incidence and mortality in Europe in 2008","volume":"46","author":"Ferlay","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib3","series-title":"Fast facts: Prostate cancer","author":"Kirby","year":"2009"},{"key":"10.1016\/j.urolonc.2012.01.013_bib4","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/ijc.22788","article-title":"Risk factors for prostate cancer incidence and progression in the health professionals follow-up study","volume":"121","author":"Giovannucci","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0090-4295(02)01637-0","article-title":"Epidemiologic association between prostatitis and prostate cancer","volume":"60","author":"Dennis","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.01.013_bib6","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1158\/1055-9965.EPI-05-0913","article-title":"Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer","volume":"15","author":"Sutcliffe","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.01.013_bib7","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/carcin\/bgh317","article-title":"Prostate carcinogenesis and inflammation: Emerging insights","volume":"26","author":"Palapattu","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.urolonc.2012.01.013_bib8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrc2090","article-title":"Inflammation in prostate carcinogenesis","volume":"7","author":"De Marzo","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib9","first-page":"351","article-title":"Cancer of prostate; its relationship to circumcision","volume":"8","author":"Ravich","year":"1952","journal-title":"Acta Unio Int Contra Cancrum"},{"key":"10.1016\/j.urolonc.2012.01.013_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/oxfordjournals.epirev.a000781","article-title":"Sexual behavior and evidence for an infectious cause of prostate cancer","volume":"23","author":"Strickler","year":"2001","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.urolonc.2012.01.013_bib11","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1054\/bjoc.1999.0986","article-title":"Sexual behaviour, STDs and risks for prostate cancer","volume":"82","author":"Hayes","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib12","first-page":"506","article-title":"Prostate cancer and sexually transmitted diseases: A meta-analysis","volume":"37","author":"Taylor","year":"2005","journal-title":"Fam Med"},{"key":"10.1016\/j.urolonc.2012.01.013_bib13","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1158\/1055-9965.EPI-08-0173","article-title":"Sexually transmissible infections and prostate cancer risk","volume":"17","author":"Huang","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.01.013_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.urolonc.2006.09.014","article-title":"Inflammation in the etiology of prostate cancer: An epidemiologic perspective","volume":"25","author":"Sutcliffe","year":"2007","journal-title":"Urol Oncol"},{"issue":"Suppl 10","key":"10.1016\/j.urolonc.2012.01.013_bib15","doi-asserted-by":"crossref","first-page":"K17","DOI":"10.1016\/j.vaccine.2008.06.021","article-title":"Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions","volume":"26","author":"Giuliano","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.urolonc.2012.01.013_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/jcm.28.3.409-412.1990","article-title":"Detection of human papillomavirus DNA in Prostate Gland tissue by using the polymerase chain reaction amplification assay","volume":"28","author":"McNicol","year":"1990","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11845-011-0692-6","article-title":"Human papillomavirus 16 or 18 infection and prostate cancer risk: A meta-analysis","volume":"180","author":"Lin","year":"2011","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.urolonc.2012.01.013_bib18","first-page":"5991","article-title":"Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas","volume":"52","author":"Anwar","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2012.01.013_bib19","first-page":"823","article-title":"Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers","volume":"59","author":"Serth","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2012.01.013_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2490-5-15","article-title":"Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina","volume":"5","author":"Leiros","year":"2005","journal-title":"BMC Urol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pros.2990220210","article-title":"Detection of human papillomavirus (HPV) DNA in human prostatic tissues by polymerase chain reaction (PCR)","volume":"22","author":"Sarkar","year":"1993","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2012.01.013_bib22","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1118::AID-CNCR16>3.0.CO;2-9","article-title":"A multifaceted study of human papillomavirus and prostate carcinoma","volume":"82","author":"Strickler","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/pros.10157","article-title":"Detection of Human Polyomaviruses and Papillomaviruses in prostatic Tissue Reveals the Prostate as a Habitat for MultipleViral Infections","volume":"53","author":"Zambrano","year":"2002","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2012.01.013_bib24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1471-2407-10-326","article-title":"Identification of viral infections in the prostate and evaluation of their association with cancer","volume":"10","author":"Martinez-Fierro","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib25","first-page":"872","article-title":"Prostate cancer risk and Serologic evidence of human papilloma virus infection: A population-based Case-control study","volume":"12","author":"Adami","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.01.013_bib26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<564::AID-IJC12>3.0.CO;2-9","article-title":"Sero-epidemiological association between human papillomavirus infection and risk of prostate cancer","volume":"75","author":"Dillner","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2407-11-53","article-title":"Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: A case-control study","volume":"11","author":"Hrbacek","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib28","first-page":"172","article-title":"Genitourinary tract infections in patient history do not correlate with prostate cancer biological behaviour and prognosis","volume":"15","author":"Hrbacek","year":"2011","journal-title":"Ces Urol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib29","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/ijc.24144","article-title":"Trichomonosis and subsequent risk of prostate cancer in the prostate cancer prevention trial","volume":"124","author":"Sutcliffe","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib30","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the United States, 1988\u20131994","volume":"43","author":"Staras","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.urolonc.2012.01.013_bib31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/01.ju.0000080263.46164.97","article-title":"High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma","volume":"170","author":"Samanta","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib32","first-page":"819","article-title":"Human cytomegalovirus and herpes simplex type 2 virus in normal and adenocarcinomatous prostate glands","volume":"70","author":"Boldogh","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2012.01.013_bib33","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3181\/00379727-174-41740","article-title":"Herpesvirus RNA in human urogenital tumors","volume":"174","author":"Eizuru","year":"1983","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.urolonc.2012.01.013_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.bjc.6603480","article-title":"No link between viral findings in the prostate and subsequent cancer development","volume":"96","author":"Bergh","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0090-4295(02)02166-0","article-title":"Herpes simplex virus, cytomegalovirus, and papillomavirus DNA are not found in patients with chronic pelvic pain syndrome undergoing radical prostatectomy for localized prostate cancer","volume":"61","author":"Leskinen","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.01.013_bib36","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/pros.20680","article-title":"A molecular analysis of Prokaryotic and Viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms","volume":"68","author":"Sfanos","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2012.01.013_bib37","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1086\/340041","article-title":"Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988\u20131994","volume":"185","author":"Xu","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.urolonc.2012.01.013_bib38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0022-5347(17)55039-9","article-title":"The relationship of herpesvirus to carcinoma of the prostate","volume":"125","author":"Baker","year":"1981","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib39","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1158\/1055-9965.EPI-08-1167","article-title":"Sexually transmitted infections and prostate cancer among men in the U.S. Military","volume":"18","author":"Dennis","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.01.013_bib40","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1086\/430354","article-title":"No serological evidence of association between prostate cancer and infection with herpes simplex virus type 2 or human herpesvirus type 8: A nested case-control study","volume":"191","author":"Korodi","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.urolonc.2012.01.013_bib41","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1056\/NEJM199605023341805","article-title":"Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen","volume":"334","author":"Monini","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2012.01.013_bib42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0022-5347(01)64038-2","article-title":"Kaposi's sarcoma associated herpesvirus deoxyribonucleic acid sequences: Lack of detection in prostatic tissue of human immunodeficiency virus-negative immunocompetent adults","volume":"159","author":"Rubin","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib43","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1128\/JVI.72.7.6223-6227.1998","article-title":"Human herpesvirus 8 in the prostate glands of men with Kaposi's sarcoma","volume":"72","author":"Diamond","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib44","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM199610173351614","article-title":"Absence of HHV-8 in prostate and semen","volume":"335","author":"Corbellino","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2012.01.013_bib45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00002030-199702000-00016","article-title":"Human herpesvirus 8 in semen and prostate","volume":"11","author":"Blackbourn","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.urolonc.2012.01.013_bib46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1086\/380568","article-title":"Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer","volume":"189","author":"Hoffman","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.urolonc.2012.01.013_bib47","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1158\/1055-9965.EPI-07-0134","article-title":"Serum antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: A prospective study","volume":"16","author":"Sutcliffe","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.01.013_bib48","first-page":"4876","article-title":"Demonstration of Epstein-Barr virus in carcinomas of various sites","volume":"62","author":"Grinstein","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2012.01.013_bib49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-9378-1-2","article-title":"Antibodies against six human herpesviruses in relation to seven cancers in black South Africans: A case control study","volume":"1","author":"Gonz\u00e1lez","year":"2006","journal-title":"Infect Agents Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib50","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1038\/sj.onc.1206550","article-title":"Oncogenic transformation by BK virus and association with human tumors","volume":"22","author":"Tognon","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2012.01.013_bib51","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/viro.1995.9928","article-title":"DNA rearrangements impairing BK virus productive infection in urinary tract tumors","volume":"214","author":"Monini","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.urolonc.2012.01.013_bib52","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.1038\/sj.onc.1207920","article-title":"Detection and expression of human BK virus sequences in neoplastic prostate tissues","volume":"23","author":"Das","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2012.01.013_bib53","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1128\/JVI.02461-07","article-title":"BK virus as a cofactor in the etiology of prostate cancer in its early stages","volume":"82","author":"Das","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib54","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/jmv.21312","article-title":"p53 gene mutational rate, Gleason score, and BK virus infection in prostate adenocarcinoma: Is there a correlation?","volume":"80","author":"Russo","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib55","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/sj.bjc.6602869","article-title":"Antibody levels against BK virus and prostate, kidney and bladder cancers in the EPIC-Oxford cohort","volume":"93","author":"Newton","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib56","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00345-005-0047-x","article-title":"Chlamydial infections in urology","volume":"24","author":"Wagenlehner","year":"2006","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib57","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1158\/1055-9965.EPI-03-0325","article-title":"Chlamydial antibodies and risk of prostate cancer","volume":"14","author":"Antilla","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.01.013_bib58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2605.1996.tb00446.x","article-title":"Detection of Chlamydia trachomatis in the prostate by in-situ hybridization and by transmission electron microscopy","volume":"19","author":"Corradi","year":"1996","journal-title":"Int J Androl"},{"key":"10.1016\/j.urolonc.2012.01.013_bib59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/QCO.0b013e3282f3d999","article-title":"Global epidemiology and control of Trichomonas vaginalis","volume":"21","author":"Johnston","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.urolonc.2012.01.013_bib60","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/1055-9965.EPI-05-0781","article-title":"Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer","volume":"15","author":"Sutcliffe","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.01.013_bib61","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1158\/1535-7163.MCT-05-0040","article-title":"p37 induces tumor invasiveness","volume":"4","author":"Ketcham","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.urolonc.2012.01.013_bib62","doi-asserted-by":"crossref","first-page":"e6872","DOI":"10.1371\/journal.pone.0006872","article-title":"Persistent exposure to mycoplasma induces malignant transformation of human prostate cells","volume":"4","author":"Namiki","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.urolonc.2012.01.013_bib63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/1471-2407-11-233","article-title":"Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate cancer","volume":"11","author":"Urbanek","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib64","doi-asserted-by":"crossref","first-page":"289","DOI":"10.18632\/oncotarget.256","article-title":"Association of Mycoplasma hominis infection with prostate cancer","volume":"2","author":"Barykova","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.urolonc.2012.01.013_bib65","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0022-5347(05)67145-5","article-title":"Bacterial dna sequences in prostate tissue from patients with prostate cancer and chronic prostatitis","volume":"164","author":"Krieger","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib66","first-page":"1127","article-title":"Association between the presence of bacterial 16S RNA in prostate specimens taken during transurethral resection of prostate and subsequent risk of prostate cancer (Sweden)","volume":"17","author":"Alexeyev","year":"2006","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urolonc.2012.01.013_bib67","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1128\/JCM.01543-07","article-title":"Direct visualization of Propionibacterium acnes in prostate tissue by multicolor fluorescent in situ hybridization assay","volume":"45","author":"Alexeyev","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijmm.2010.08.014","article-title":"Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells","volume":"301","author":"Fassi Fehri","year":"2011","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib69","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.bjc.6605757","article-title":"Plasma concentration of Propionibacterium acnes antibodies and prostate cancer risk: Results from an Australian population-based case-control study","volume":"103","author":"Severi","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib70","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1371\/journal.ppat.0020025","article-title":"Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNaseL variant","volume":"2","author":"Urisman","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.urolonc.2012.01.013_bib71","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.biochi.2007.02.006","article-title":"Diverse functions of RNase L and implications in pathology","volume":"89","author":"Bisbal","year":"2007","journal-title":"Biochimie"},{"key":"10.1016\/j.urolonc.2012.01.013_bib72","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/jir.2010.0120","article-title":"New insights into the role of RNase L in innate immunity","volume":"31","author":"Chakrabarti","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.urolonc.2012.01.013_bib73","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1742-4690-7-111","article-title":"Disease-associated XMRV sequences are consistent with laboratory contamination","volume":"7","author":"Hu\u00e9","year":"2010","journal-title":"Retrovirology"},{"key":"10.1016\/j.urolonc.2012.01.013_bib74","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1126\/science.333.6050.1694","article-title":"Virology","volume":"333","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2012.01.013_bib75","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/jbiol168","article-title":"Infectious causes of cancer and their detection","volume":"8","author":"Dalton-Griffin","year":"2009","journal-title":"J Biol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib76","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0022-5347(17)38476-8","article-title":"High prevalence of human papillomavirus in prostate tissues","volume":"145","author":"McNicol","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib77","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00007611-199102000-00020","article-title":"Human papillomavirus in prostatic cancer: No evidence found by in situ hybridization","volume":"84","author":"Masood","year":"1991","journal-title":"South Med J"},{"key":"10.1016\/j.urolonc.2012.01.013_bib78","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0022-5347(17)37195-1","article-title":"Human papillomavirus types 16 and 18 are not involved in human prostate carcinogenesis: Analysis of archival human prostate cancer specimens by differential polymerase chain reaction","volume":"147","author":"Effert","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib79","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0022-5347(17)36551-5","article-title":"Human papillomavirus and herpes virus DNA are not detected in benign and malignant prostastic tissue using the polymerase chain reaction","volume":"148","author":"Serfling","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib80","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ijc.2910520306","article-title":"Presence and physical state of HPV DNA in prostate and urinary tract tissues","volume":"52","author":"Rotola","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib81","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/S0022-5347(17)37040-4","article-title":"Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization","volume":"148","author":"Ibrahim","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib82","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0022-5347(17)36103-7","article-title":"Detection of human papillomavirus 16 transcription in human prostate tissue","volume":"149","author":"Dodd","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib83","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pros.2990220210","article-title":"Detection of human papillomavirus (HPV) DNA in human prostatic tissues by polymerase chain reaction (PCR)","volume":"22","author":"Sarkar","year":"1993","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2012.01.013_bib84","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0090-4295(94)80215-7","article-title":"Rare incidence of human papillomavirus types 16 and 18 in primary and metastatic human prostate cancer","volume":"44","author":"Tu","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.01.013_bib85","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ijc.2910640209","article-title":"p53 and HPV status in benign and malignant prostate tumors","volume":"64","author":"Moyret-Lalle","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib86","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/(SICI)1097-0045(199605)28:5<318::AID-PROS8>3.0.CO;2-7","article-title":"Detection of human papillomavirus DNA and p53 Gene mutations in human prostate cancer","volume":"28","author":"Suzuki","year":"1996","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2012.01.013_bib87","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1097-0045(199602)28:2<117::AID-PROS7>3.0.CO;2-D","article-title":"Human papillomavirus DNA in malignant and hyperplastic prostate tissue of Black and White males","volume":"28","author":"Wideroff","year":"1996","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2012.01.013_bib88","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1096-9071(199705)52:1<8::AID-JMV2>3.0.CO;2-8","article-title":"Analysis of prostate tissue DNA for the presence of human papillomavirus by polymerase chain reaction, cloning, and automated sequencing","volume":"52","author":"Anderson","year":"1997","journal-title":"J Med Virol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib89","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s002400050041","article-title":"Detection of human papillomavirus (HPV) DNA in archival specimens of benign prostatic hyperplasia and prostatic cancer using a highly sensitive nested PCR method","volume":"26","author":"Noda","year":"1998","journal-title":"Urol Res"},{"key":"10.1016\/j.urolonc.2012.01.013_bib90","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1118::AID-CNCR16>3.0.CO;2-9","article-title":"A multifaceted study of human papillomavirus and prostate carcinoma","volume":"82","author":"Strickler","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib91","first-page":"834","article-title":"Absence of human papillomavirus sequences in early stage prostate cancer","volume":"6","author":"Saad","year":"1999","journal-title":"Can J Urol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib92","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/172460080401900401","article-title":"Association of human papillomavirus with prostate cancer: Analysis of a consecutive series of prostate biopsies","volume":"19","author":"Carozzi","year":"2004","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.urolonc.2012.01.013_bib93","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/172460080702200402","article-title":"Prevalence of BK virus and human papillomavirus in human prostate cancer","volume":"22","author":"Balis","year":"2007","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.urolonc.2012.01.013_bib94","doi-asserted-by":"crossref","first-page":"633","DOI":"10.15537\/1658-3175.4715","article-title":"Lack of detection of human papillomavirus infection by hybridization test in prostatic biopsies","volume":"30","author":"Gazzaz","year":"2009","journal-title":"Saudi. J Med"},{"key":"10.1016\/j.urolonc.2012.01.013_bib95","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1590\/S0074-02762009000400024","article-title":"Low frequency of human papillomavirus detection in prostate tissue from individuals from Northern Brazil","volume":"104","author":"Silvestre","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.urolonc.2012.01.013_bib96","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/00365548.2010.502904","article-title":"The role of human papillomavirus infection in prostate carcinoma","volume":"43","author":"Aghakhani","year":"2011","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.urolonc.2012.01.013_bib97","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0022-5347(17)55039-9","article-title":"The relationship of herpesvirus to carcinoma of the prostate","volume":"125","author":"Baker","year":"1981","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib98","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0090-4295(84)90118-3","article-title":"Immunofluorescent evidence of prior herpes simplex virus type-2 infection in prostate carcinoma","volume":"24","author":"Haid","year":"1984","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.01.013_bib99","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1182\/blood.V89.5.1686","article-title":"Is Kaposi's sarcoma-associated herpesvirus ubiquitous in urogenital and prostate tissues?","volume":"89","author":"Tasaka","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.urolonc.2012.01.013_bib100","first-page":"70","article-title":"Absence of human herpesvirus 8 sequence in prostate specimens","volume":"11","author":"Lebb\u00e9","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.urolonc.2012.01.013_bib101","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1600-0463.2007.apm_601.x","article-title":"Low frequency of BK virus in prostatic adenocarcinomas","volume":"115","author":"Lau","year":"2007","journal-title":"APMIS"},{"key":"10.1016\/j.urolonc.2012.01.013_bib102","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/(SICI)1097-0215(19960611)66:6<717::AID-IJC1>3.0.CO;2-2","article-title":"Latent BK virus infection and Kaposi's sarcoma pathogenesis","volume":"66","author":"Monini","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib103","article-title":"No evidence for a role of xenotropic murine leukaemia virus-related virus and BK virus in prostate cancer of German patients","author":"Akg\u00fcl","year":"2011","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib104","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jama.283.3.340-a","article-title":"Human papillomavirus antibody and risk of prostate cancer","volume":"3","author":"Hisada","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2012.01.013_bib105","first-page":"763","article-title":"Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer","volume":"12","author":"Rosenblatt","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.01.013_bib106","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1158\/1055-9965.EPI-05-0602","article-title":"Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: A Nordic nested case-control study","volume":"14","author":"Korodi","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.01.013_bib107","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1750-9378-2-6","article-title":"The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population","volume":"2","author":"Sitas","year":"2007","journal-title":"Infect Agents Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib108","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1158\/1055-9965.EPI-07-0134","article-title":"Serum antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: A prospective study","volume":"16","author":"Sutcliffe","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.01.013_bib109","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1158\/1055-9965.EPI-09-1080","article-title":"Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the prostate cancer prevention trial","volume":"19","author":"Sutcliffe","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.01.013_bib110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/geronj\/42.3.259","article-title":"Sexual factors and prostatic cancer: Results from a case-control study","volume":"42","author":"Mandel","year":"1987","journal-title":"J Gerontol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib111","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1086\/518790","article-title":"Human herpesvirus 8 seroprevalence among prostate cancer case patients and control subjects","volume":"196","author":"Jenkins","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.urolonc.2012.01.013_bib112","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-9378-6-25","article-title":"A case-cohort study of human herpesvirus 8 seropositivity and incident prostate cancer in Tobago","volume":"6","author":"McDonald","year":"2011","journal-title":"Infect Agents Cancer"},{"key":"10.1016\/j.urolonc.2012.01.013_bib113","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/jnci\/djp306","article-title":"Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' health study","volume":"101","author":"Stark","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2012.01.013_bib114","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcv.2008.04.016","article-title":"Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer","volume":"43","author":"Fischer","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1016\/j.urolonc.2012.01.013_bib115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1742-4690-6-92","article-title":"Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients","volume":"6","author":"Hohn","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.urolonc.2012.01.013_bib116","doi-asserted-by":"crossref","first-page":"16351","DOI":"10.1073\/pnas.0906922106","article-title":"XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors","volume":"106","author":"Schlaberg","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2012.01.013_bib117","doi-asserted-by":"crossref","first-page":"10028","DOI":"10.1158\/0008-5472.CAN-10-2837","article-title":"XMRV: A new virus in prostate cancer?","volume":"70","author":"Aloia","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2012.01.013_bib118","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.urology.2010.01.038","article-title":"XMRV infection in patients with prostate cancer: Novel serologic assay and correlation with PCR and FISH","volume":"75","author":"Arnold","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.01.013_bib119","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1086\/656146","article-title":"Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions","volume":"15","author":"Danielson","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.urolonc.2012.01.013_bib120","article-title":"Prevalence of XMRV infection in different risk populations in Spain","author":"Arredondo","year":"2011","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.urolonc.2012.01.013_bib121","first-page":"8","article-title":"No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan","volume":"17","author":"Furuta","year":"2011","journal-title":"Retrovirology"},{"key":"10.1016\/j.urolonc.2012.01.013_bib122","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-4690-8-23","article-title":"No evidence of XMRV in prostate cancer cohorts in the midwestern United States","volume":"8","author":"Sakuma","year":"2011","journal-title":"Retrovirology"},{"key":"10.1016\/j.urolonc.2012.01.013_bib123","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.mcp.2011.01.005","article-title":"No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls","volume":"25","author":"Sabunciyan","year":"2011","journal-title":"Mol Cell Probes"},{"key":"10.1016\/j.urolonc.2012.01.013_bib124","doi-asserted-by":"crossref","first-page":"e25592","DOI":"10.1371\/journal.pone.0025592","article-title":"No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe","volume":"6","author":"Stieler","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.urolonc.2012.01.013_bib125","doi-asserted-by":"crossref","first-page":"e19065","DOI":"10.1371\/journal.pone.0019065","article-title":"No association of xenotropic murine leukemia virus-related viruses with prostate cancer","volume":"6","author":"Switzer","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.urolonc.2012.01.013_bib126","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/pros.21255","article-title":"Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in Dutch prostate cancer patients","volume":"71","author":"Verhaegh","year":"2011","journal-title":"Prostate"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143912000439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143912000439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:10:33Z","timestamp":1786450233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143912000439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":126,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1078143912000439"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2012.01.013","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thirty years of research on infection and prostate cancer: No conclusive evidence for a link. A systematic review","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2012.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}